Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Foundation for Research in Genetics and Endocrinology, |
RCV004577656 | SCV005061486 | uncertain significance | Type 2 diabetes mellitus | 2024-06-15 | criteria provided, single submitter | clinical testing | A heterozygous missense variant in exon 5 of the TCF7L2 gene that results in the amino acid substitution of Glutamic acid for Aspartic acid at codon 160 was detected. The observed variant c.480T>G (p.Asp160Glu) has not been reported in the 1000 genomes and gnomAD databases. The in silico prediction of the variant are possibly damaging by PolyPhen-2 (HumDiv) and damaging by LRT and SIFT. The reference codon is conserved across species. In summary, the variant meets our criteria to be classified as a variant of uncertain significance. |